Efficacy of Osteopathic Manipulative Techniques With Progressive Pulmonary Fibrosis Patients

April 21, 2026 updated by: Ola Ali Mohamed Tamim, Beni-Suef University

Efficacy of Selected Osteopathic Manipulative Techniques as a Conjunctive Therapy for Patients With Progressive Pulmonary Fibrosis

The goal of this clinical trial is to learn if osteopathic manipulative techniques add benefits for treatment of patients with progressive pulmonary fibrosis. The main questions it aims to answer are :

Could osteopathic manipulative techniques add benefits for treatment of patients with progressive pulmonary fibrosis? Researchers will compare osteopathic manipulative techniques with chest physiotherapy to chest physiotherapy alone to see if osteopathic manipulative techniques works to treat progressive pulmonary fibrosis.

Participants will:

Take osteopathic manipulative techniques 2 days a week for 4 weeks and chest physiotherapy 3 days a week for 4 weeks

Study Overview

Detailed Description

In this study researchers want to see if osteopathic manipulative techniques add benefits to treat progressive pulmonary fibrosis.

two group of patients : study group will receive osteopathic manipulative techniques with conventional chest physiotherapy .

control group will receive only conventional chest physiotherapy . osteopathic manipulative techniques will be done for 2 days a week for 4 weeks while conventional chest physiotherapy will be done 3 days a week for 4 weeks.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Their age > 18.
  • Both sexes.
  • Patients without excerbations.
  • FVC of the patient <50% .
  • FEV1/ FVC of the patient <50%.
  • Hemodynamic stable.
  • Conscious and cooperative.
  • Are able to participate in training actively.

Exclusion Criteria:

  • Patients with acute excerbations.

    • Acute or Uncontrolled Infections.
    • Active Malignancy.
    • Chest deformity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: OMT and chest physiotherapy
for 4 weeks , 2 sessions per week
Active Comparator: conventional chest physiotherapy
for 4 weeks , 3 sessions per week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pulmonary function test - FVC
Time Frame: preintervention , post intervention after 4 weeks
FVC
preintervention , post intervention after 4 weeks
pulmonary function test - FEV
Time Frame: pre intervention , post intervention after 4 weeks
FEV
pre intervention , post intervention after 4 weeks
pulmonary function test - FEV/FVC
Time Frame: pre intervention , post intervention after 4 weeks
FEV/FVC
pre intervention , post intervention after 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
chest expansion measurment
Time Frame: pre intervention , post intervention after 4 weeks
pre intervention , post intervention after 4 weeks
Modified Medical Research Council dyspnea scale
Time Frame: pre intervention , post intervention after 4 weeks
Minimum value: 0 Maximum value:4 Higher scores indicate a worse outcome (more severe dyspnea)
pre intervention , post intervention after 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tamer I Abo elyazed, professor, Beni-Suef University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

October 1, 2027

Study Registration Dates

First Submitted

April 14, 2026

First Submitted That Met QC Criteria

April 21, 2026

First Posted (Actual)

April 23, 2026

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • FPTBSUREC/0405/2325

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteopathic Manipulative Treatment

Clinical Trials on osteopathic manipulative techniques

Subscribe